In sporadic ccRCC, it is estimated that >90% of patients have a loss of VHL heterozygosity, and inactivating VHL mutations are found in 50–65% of cases [10] (reviewed in reference 10). Here, VHL is linked to nonpapillary renal cell carcinoma.